Menu
Recruiting NCT07525713

Virtual Reality Mirror Therapy With Focused Object-Directed Attention System

No phase Interventional Stroke Rehabilitation Virtual Reality Mirror Movement Therapy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: task-oriented training.
Who it may be relevant to
Registry conditions: Stroke, Rehabilitation, Virtual Reality, Mirror Movement Therapy. Basic parameters: 20 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Virtual Reality Mirror Therapy With Focused Object-Directed Attention for Neuro-Rehabilitation

Overview

In this study, the investigators hypothesized that Virtual Reality Mirror Therapy with Focused Object-Directed Attention (VRMTFOA) would yield superior therapeutic effects compared to conventional Virtual Reality Mirror Therapy (VRMT) in individuals with unilateral stroke. The aim of this study is to compare the immediate effects of a single session of VRMT, VRMTFOA, and VRMTFOA with auditory feedback on upper extremity function and brain activity in stroke patients.

Interventions

  • Other task-oriented training
    Virtual Reality Mirror Therapy combined with Motor training targeted to goals that are relevant to the functional needs of the patient

Primary outcome measures

  • Change in the result of Fugl-Meyer assessment (FMA) for motor function of upper extremity test [Time frame: baseline, 9 weeks and 21 weeks]
Secondary outcome measures (6)
  • Change in the result of Modified Ashworth scale (MAS) [Time frame: baseline, 9 weeks and 21 weeks]
  • Change in the result of Box and blocks test [Time frame: baseline, 9 weeks and 21 weeks]
  • Change in the result of Semmes-Weinstein monofilament (SWM) test [Time frame: baseline, 9 weeks and 21 weeks]
  • Change in the result of Motor Activity Log [Time frame: baseline, 9 weeks and 21 weeks]
  • Surface electromyography (sEMG) [Time frame: baseline, 9 weeks]
  • Clinical Global Impression (CGI) scale [Time frame: 9 weeks]

Eligibility criteria

Inclusion criteria

  • Clinical diagnosis of stroke with unilateral side involved;
  • A score of Mini-mental state examination greater than 24 for proving higher mental function;
  • Time of onset > 6 months before treatment begins;
  • Premorbid right-handedness.

Exclusion criteria

  • Severe vision impairment;
  • Major cognitive-perceptual deficit;
  • Other brain disease.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Taiwan · 1 center
  • National Cheng-Kung University Hospital — Tainan

Identifiers

NCT: NCT07525713 · A-ER-114-469

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗